Stem cells and kidney diseases

Minerva Medica

Volumn 95, Issue 5, 2004, Pages 411-418

  Abbattista, M R ^a   Schena, F P ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Bone marrow cells; Cell therapy; Stem cells

Indexed keywords

COLLAGEN;

ACUTE KIDNEY FAILURE; ADOPTIVE IMMUNOTHERAPY; CELL ACTIVITY; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; DRUG DELIVERY SYSTEM; EMBRYO; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; FETUS DEATH; GLOMERULUS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOTHERAPY; INFLAMMATORY CELL; KIDNEY CELL; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY SCAR; KIDNEY TUBULE; ORGAN; PATHOPHYSIOLOGY; PHENOTYPE; REGENERATION; REVERSE DIFFERENTIATION; REVIEW; STEM CELL; SUBSTITUTION THERAPY; TISSUE ENGINEERING; TISSUE REGENERATION; UMBILICAL CORD BLOOD;

ADULT; BIOMEDICAL RESEARCH; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; CHILD; FEMALE; FETAL RESEARCH; FETUS; GENE THERAPY; HEMATOPOIETIC STEM CELLS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; TISSUE THERAPY;

EID: 8344220460     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Metcalf D. Hematopoietic stem cells: old and new. Biomed Pharmacother 2001;55:75-8.
2. Reubinoff BE, Fera MF, Fong C, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404.
3. Koh CJ, Atala A. Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol 2004;15;1113-25.
4. Hochedlinger K, Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl J Med 2003;349:275-86.
5. McKay R. Stem cells in the central nervous system. Science 1997;276:66-71.
6. Morrison SJ, Wright DE, Cheshier SH, Weissman IL. Hematopoietic stem cells: challenges to expectations. Curr Opin Immunol 1997;9:216-21.
7. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
8. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-34.
9. Okamoto R, Yajima T, Yamazaki M, Kanai T, Mukai M, Okamoto S et al. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med 2002;8:1011-7.
10. Wertz DC. Embryo and stem cell research in the United States: history and politics. Gene Ther 2002;9:674-8.
11. Morrison SJ, White PM, Zock C, Anderson DJ. Prospective identification, isolation, by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 1999;96:737-49.
12. Mollura DJ, Hare JM, Rabb H. Stem-cell therapy for renal diseases. Am J Kidney Dis 2003;42:891-905.
13. Herzlinger D, Koseki C, Mikawa T, Al-Awqati Q. Metanephric mesenchyme contains multipotent cells whose fate is restricted after induction. Development 1992;114:565-72.
14. Medvinsky AL, Samoylina NL, Muller AM, Dzierzak EA. An early pre-liver intraembryonic source of CFUS in the developing mouse. Nature 1993;364:64-7.
15. Maeshima A, Yamashita S, Nojima Y. Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol 2003;14:3138-46.
16. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-6.
17. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996;334:1448-60.
18. Hammerman MR, Miller SB. Therapeutic use of growth factors in renal failure. J Am Soc Nephrol 1994;5:1-11.
19. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 2003;14:555-61.
20. El Nahas AM. Plasticity of kidney cells: role in kidney remodelling and scarring. Kidney Int 2003;64:1553-63.
21. Savage COS. The biology of the glomerulus: endothelial cells. Kidney Int 1994;45:314-9.
22. El Nahas AM, Muchaneta-Kubara EC, Essawy M, Soylemez-Oglu O, Renal fibrosis: insights into pathogenesis and treatment. Int J Biochem Cell Biol 1997;29:55-62.
23. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell 2001;105:829-41.
24. Ito T, Suzuki A, Imai E, Okabe M, Hori M. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodelling. J Am Soc Nephrol 2001;12:2625-35.
25. Imasawa T, Utsunomiya Y, Kawamura T, Zhong Y, Nagasawa R, Okabe M et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 2001;12:1401-9.
26. Hasely LA, Hugo C, Reidy MA, Johnson RJ. Dissociation of mesangial cell migration and proliferation in experimental glomerulonephritis. Kidney Int 1999;56:964-72.
27. Lindahl P, Hellstrom M, Kalen M, Karlsson L, Pekny M, Pekna M et al. Paracrine PDGF-B/PDGF-Rb signaling controls mesangial cell development in kidney glomeruli. Development 1998;125:3313-22.
28. Zeisberg M, Strutz F, Muller GA. Renal fibrosis: an update. Curr Opin Nephrol Hypertens 2000;10:315-20.
29. Poulsom R, Forbes SJ, Hodivala-Dilke K, Ryan E, Wyles S, Navaratnarasah S et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001;195:229-35.
30. Gupta S, Verfaillie C, Chmielewski D, Kim Y, Rosenberg ME. A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int 2002;62:1285-90.
31. Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004;15:1794-804.
32. Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 2001;59:2023-38.
33. Kale SKA, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 2003;112:42-9.
34. Imai E, Ito T. Can bone marrow differentiate into renal cells? Pediatr Nephrol 2002;17:790-4.
35. Humes HD, Fissell WH, Weitzel WF. The bioartifidal kidney in the treatment of acute renal failure. Kidney Int Suppl 2002;80:S121-5.
36. Vollweiler JL, Zielske SP, Reese JS, Gerson SL. Hematopoietic stem cell gene therapy: progress toward therapeutic targets. Bone Marrow Transplant 2003;32:1-7.
37. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-6.
38. Tomasoni S, Azzollini N, Casiraghi F, Caporossi MC, Remuzzi G, Benigni A. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allografts. J Am Soc Nephrol 2000;11:747-52.
39. Fishman M, Antonia S. Novel therapies for renal carcinoma. An update. Expert Opin Invest Drugs 2003;12:593-609.
40. Azuma T, Horie S, Tomita K, Takahashi T, Tanaka Y, Kashiwase K et al. Dendritic cell immunotherapy for patients with metastatic renal cell carcinoma: University of Tokyo experience. Int J Urol 2002;9:340-6.
41. Joki T, Machluf M, Atala A, Zhu J, Seyfried NT, Dunn IF et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 2001;19:35-9.
42. Humes HD, MacKay SM, Funke AJ, Buffington DA. Acute renal failure: growth factors, cell therapy, and gene therapy. Proc Assoc Am Phys 1997;109:547-57.
43. Hagège AA, Carrion C, Menaschè P, Vilquin JT, Duboc D, Marolleau JP et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003;361:491-2.
44. Lanza RP, Chung HY, Yoo JJ, Wettstein PJ, Blackwell C, Borson N et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol 2002;20:689-96.
45. Dunnett SB, Bjorklund A, Lindvall O. Cell therapy in Parkinson's disease. Stop or go? Nat Rev Neurosci 2001;2:365-9.
46. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzer B et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83.